Suggestions
Peter van Leusden ️
Patient Journey Partner - Oncology pipeline at Roche
Professional Background
Peter van der Wal is a seasoned expert in the field of oncology and healthcare management, known for his dedicated efforts to optimize patient care through collaboration within the healthcare ecosystem. With a rich career at Roche, one of the leading pharmaceutical companies, he has effectively served in various roles, including Patient Journey Partner for the Oncology pipeline, where he works tirelessly to enhance the patient experience by bridging the gap between healthcare providers, pharmaceutical companies, and patients. Peter believes that creating an ecosystem where all parties collaborate closely is essential for advancing precision oncology and ensuring that patients have access to the highest quality of care.
His prior roles at Roche include significant positions such as imCORE Scientific Alliance Relationship Manager, Field Medical Specialist, Medical Science Liaison, and Country Study Officer. Each of these roles has allowed him to deepen his understanding of oncological care while advocating for patient inclusion in the decision-making processes affecting their health. Peter’s strategic insight into the healthcare landscape is complemented by his extensive experience in managing complex relationships across the board, including with healthcare professionals, insurers, governmental bodies, and patient associations.
Additionally, Peter’s commitment to diversity and inclusion is exemplified by his initiative to establish the OUT, PROUD, EQUALITY Network at Roche Nederland. This chapter aims to provide a platform for LGBTQ+ employees and their allies, creating an inclusive work environment where everyone feels valued and empowered. Peter’s advocacy for inclusivity extends beyond the workplace, ensuring that voices from all walks of life are heard and respected in the healthcare sector.
Education and Achievements
Peter van der Wal boasts a robust educational background that has equipped him with essential skills and knowledge in financial management, healthcare, and oncology. He began his academic journey at De Haagse Hogeschool (The Hague University of Applied Sciences), where he studied Management, Economics, and Law, laying a solid foundation for his future career.
To further enhance his expertise, he pursued Financial Management at Schouten en Nelissen and gained insights into Practical Leadership at Boertien Groep. His focus on finance is evident as he also studied Financial Policy and Investments Policy at SPO Pensioen onderwijs, reinforcing his capability to navigate the intricate financial frameworks that underpin both healthcare and pharmaceutical industries.
Peter’s commitment to understanding oncology specifically is reflected in his studies at VU / Amstel Academy, where he studied Oncology, coupled with his knowledge of Good Clinical Practice from EMWO and Monitoring studies at Leiden University. This extensive educational background underlines his multifaceted understanding of both the clinical and management aspects of healthcare, particularly in the oncology sector.
Notable Contributions
Throughout his career, Peter van der Wal has made considerable contributions to healthcare. His work as Country Study Officer and Medical Science Liaison at Roche allowed him to contribute to pivotal research studies that have advanced the field of oncology. As a Research Study Coordinator and Data Manager at HagaZiekenhuis, he was instrumental in managing clinical studies, which provided him with invaluable insights into patient care processes.
Peter also played an essential role as a member of the Board of JongHaga at HagaZiekenhuis, where he offered guidance and support for the hospital's initiatives aimed at enhancing patient care and operational efficiency.
His commitment to optimizing oncology patient care extends to ensuring that patient perspectives are a central theme in healthcare discussions. He actively collaborates with various stakeholders, including healthcare professionals, to advocate for the needs and experiences of patients navigating their cancer journey.
Conclusion
Peter van der Wal is a passionate advocate for oncology patients, dedicated to optimizing their care through collaboration and inclusivity. His extensive education in management and oncology—as well as his varied roles within Roche—demonstrate his commitment to improving healthcare outcomes for patients. With a focus on precision oncology and a strong belief in the power of inclusivity, Peter continues to make notable strides in the healthcare sector. His proactive initiatives, particularly in establishing platforms advocating for diversity at Roche, align with his larger vision of creating a healthcare environment that walks hand in hand with patients and ensures their voices are paramount in their care.